Search results
PROMOTED
Author(s):
Nicolas M Van Mieghem
,
Kendra J Grubb
,
David Hildick-Smith
,
et al
Start date:
Mar 26, 2024
Author(s):
Gregg Stone
,
Harriette Van Spall
Added:
2 years ago
Dr Gregg W Stone (Mount Sinai Heart Health System, New York, US) and Dr Harriette Van Spall (McMaster University, Hamilton, CA) discuss the latest results from the ISCHEMIA trial.
The trial assessed the impact of completeness of revascularization on clinical outcomes in patients with stable ischemic heart disease treated with an invasive versus conservative strategy.
Recorded remotely from New…
View more
Author(s):
Rasha Al-Lamee
Added:
4 years ago
Dr Rasha Al-Lamee (Imperial College London, London, UK) comments on the International Study of Comparative Health Effectiveness With Medical and Invasive Approaches in light of the ORBITA trial.
Filmed on site at AHA 2019 by Radcliffe Cardiology.
View more
Author(s):
Eduardo A Arias
,
Félix Damas-de los Santos
,
Heriberto Ontiveros-Mercado
Added:
3 years ago
For more than a decade, studies have sought to address the best treatment strategy for patients with chronic coronary syndromes (CCS), with many suggesting an invasive approach through revascularisation (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]), and others suggesting a conservative strategy, such as optimal medical therapy (OMT), for this heterogeneous…
View more
William E Boden
Job title: Professor of Medicine
Author
Jonathan Jiunn Liang Yap
Research Area(s) / Expertise:
Job title: Consultant Cardiologist
Author
Author(s):
Raffaele De Caterina
,
Carlo De Innocentiis
,
Marco Zimarino
Added:
3 years ago
Multivessel coronary artery disease (MVCAD) is defined by the presence of ≥50% diameter stenosis of two or more epicardial coronary arteries. The presence of MVCAD indicates poorer prognosis and a significantly higher mortality than single-vessel disease. In MVCAD, revascularisation can be achieved by either percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).1,2 A…
View more
Author(s):
Suleiman Suleiman
,
JJ Coughlan
,
George Touma
,
et al
Added:
3 years ago
Author(s):
Jason H Rogers
,
John R Laird
Added:
3 years ago
Critical limb ischaemia (CLI) is defined as ischaemic rest pain requiring opiate analgesics, and ulceration or gangrene of the foot or toes attributable to arterial occlusive disease.1 In contrast to patients with claudication, those with CLI have resting arterial perfusion that is inadequate to sustain the metabolic demands of the distal bed. CLI has been formally graded within the current…
View more
Author(s):
Joel P Giblett
,
Heerajnarain Bulluck
Added:
3 years ago
The translation to clinical practice of agents or techniques that protect against the effect of ischaemia–reperfusion (IR) injury remains one of the most challenging areas of research in the field of cardiovascular medicine.1–4 This is particularly the case when IR injury follows revascularisation for acute MI (AMI). The publication of the combined Effect of Remote Ischaemic Conditioning on…
View more